22nd Century Group

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, 22nd Century Group sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting 3 completed early-phase tilt upper quartile by trial count

22nd Century Group: 3 sponsored US clinical trials, none currently recruiting.

22nd Century Group sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Tobacco Use, with 1 trials.

Upper-quartile sponsor footprint

22nd Century Group sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

How the 22nd Century Group early-phase archive is shaped

3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Tobacco Use (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

22nd Century Group: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

22nd Century Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share 22nd Century Group10xBioAA SecordAAADRS Clinical Research CenterAaron Cook23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
22nd Century Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

22nd Century Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

What to do with this 22nd Century Group page

3 registered trials is a research-attention snapshot, not an endorsement of 22nd Century Group or any single study.

  • None of 22nd Century Group's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Tobacco Use is the condition 22nd Century Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Tobacco Use trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. 22nd Century Group pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.